UCB Assessing Bepranemab’s Future After Roche/Genentech Ends Partnership

Tau-Targeting Collaboration Dated Back To 2020

 
• By Mandy Jackson
  
Phase IIa data in prodromal and mild Alzheimer's disease will be presented at CTAD (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Scrip